AstraZeneca Takes Stake in Cambridge Antibody Technology alongside Antibody Discovery Alliance
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 55 (Table of Contents)
Published: 5 Jan-2005
DOI: 10.3833/pdr.v2005.i55.733 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
AstraZeneca and Cambridge Antibody entered into a strategic alliance for the joint discovery and development of human monoclonal antibodies in the field of inflammatory and respiratory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS